St Jude set to buy LightLab in $90m cash deal
This article was originally published in Clinica
Executive Summary
St Jude Medical is to become the first company to offer both optical coherence tomography (OCT) and fractional flow reserve (FFR) technology after agreeing to purchase coronary imaging specialist LightLab Imaging for $90m.
You may also be interested in...
Abbott Launches ILUMIEN IV Trial To Drive Home Case For OCT
ILUMIEN IV is the largest-ever prospective randomized trial to compare an intravascular imaging modality, plus angiography, to angiography alone in coronary interventions, according to Abbott. The trial will enroll up to 3,650 patients with high-risk complex disease at 125 centers in North America, Europe and Asia to determine if OCT-guided stenting yields larger vessel diameters and improves clinical outcomes for patients compared to stent procedures guided by standard angiography.
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.